Skip to main content

Table 1 (abstract O8). See text for description

From: Proceedings of the 27th European Paediatric Rheumatology Congress (PReS 2021)

  

All

(N=364)

Gender

Female

232 (64%)

Male

131 (36%)

Unknown

1 (<1%)

Age, years

Median (IQR)

14 (10, 17)

Top Rheumatology Diagnoses

Juvenile Idiopathic Arthritis (JIA)

244 (67%)

Polyarthritis

124 (34%)

Oligoarthritis

65 (18%)

Systemic

23 (6%)

Psoriatic

6 (2%)

Enthesitis

26 (7%)

Autoinflammatory

51 (14%)

Connective Tissue Disorder

42 (12%)

Other

27 (7%)

Comorbidities

(25 missing)

None stated

282 (77%)

Obesity

15 (4%)

Ocular inflammation

28 (8%)

Asthma

7 (2%)

Required Hospitalisation

Yes

20 (5%)

No

271 (74%)

Missing

73 (20%)

Top Symptoms Reported

Fever

146 (40%)

Cough

109 (30%)

Headache

75 (21%)

Rhinorrhea

75 (21%)

Deaths due to COVID-19

Yes

1 (<1%)

Treatment at onset of COVID-19 infection

Glucocorticoids

42 (12%)

csDMARDs

161 (44%)

Methotrexate

125 (34%)

Antimalarials

22 (6%)

Mycophenolate

17 (5%)

b/tsDMARDs

161 (44%)

Anti-TNF

119 (33%)

IL-6

21 (6%)

IL-1

12 (3%)

JAK

2 (<1%)

Any DMARD

251 (69%)

Disease Activity

Remission

146 (40%)

Low

103 (28%)

Moderate / High

31 (9%)

Unknown

84 (23%)